FTC Sues Endo, Impax, Amneal For Antitrust Pact To Monopolize Opana ER Opioids Market
(January 29, 2021, 2:12 PM EST) -- WASHINGTON, D.C. — The U.S. Federal Trade Commission on Jan. 25 filed a civil antitrust complaint against Endo Pharmaceuticals Inc., Impax Laboratories LLC and Amneal Pharmaceuticals Inc., alleging that the defendants’...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login